Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
- SFA_dividend_26062026_technical_correction_EN_espi.pdfCorrection of notification on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of "Sopharma" AD held on June 26, 2026
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 203 | / | 2026 | ||||||||
| Date of issue: | 2026-06-26 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Correction of notification on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of "Sopharma" AD held on June 26, 2026 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56. 1. 2 of Act on Public Offering | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria, June 26, 2026 – “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies of an error in the text of notification with out. number 194-00-162 as of June 26, 2026 on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of "Sopharma" AD held on June 26, 2026 The text “The General Meeting of Shareholders approved the proposal of the Board of Directors to distribute a gross dividend to shareholders in the amount of EUR 0.052 /5.2 euro cents/ per share.” should read “The General Meeting of Shareholders approved the proposal of a shareholder made during the discussion under item 7 of the AGM to distribute a gross dividend to shareholders in the amount of EUR 0.052 /5.2 euro cents/ per share.” We apologize for the inconvenience. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA_dividend_26062026_technical_correction_EN_espi.pdf SFA_dividend_26062026_technical_correction_EN_espi.pdf | Correction of notification on the terms and conditions for distribution of the dividend voted at the Annual General Meeting of Shareholders of "Sopharma" AD held on June 26, 2026 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2026-06-26 | Ognian Donev | Executive Director | |||
